Wang Yi, general manager of sina.com business center

On December 28, 2019, under the guidance of China Pharmaceutical Materials Association, the "2019 China Pharmaceutical New Smart exchange forum" jointly sponsored by Sina pharmaceutical and China Pharmaceutical Materials Association think tank in the food and drug industry was held in Beijing The theme of this conference is "gather wisdom and generate wisdom in a big wave" Industry experts and enterprise representatives gather to find out the variables and future of China's pharmaceutical industry and talk about the next golden decade of industrial development! "Keynote speech was delivered at the meeting Wang Yi, general manager of sina business center The following is the original speech: Dear leaders, guests and media friends, good morning Welcome to the "2019 China Pharmaceutical new wisdom Forum & value pioneer list award ceremony" jointly sponsored by Sina Pharmaceutical News and the think tank of food and drug industry of China Pharmaceutical Materials Association Here, on behalf of sina.com, please allow me to extend a warm welcome to all of you and heartfelt thanks for your participation and support In the past few decades, China's pharmaceutical and health industry has experienced unprecedented rapid development We are keen to find that the whole country has made significant breakthroughs in biomedicine, bioengineering, health new economy and other fields As the leader of Internet media in China, we hope to stay at the forefront of the industry and lead the development of the industry In order to record the times and influence the times, Sina medical news came into being in 2016 For more than three years, Sina medical news has been continuously providing more, better and more authoritative news and information services to the public, and constantly improving and disseminating its own value and influence Now, 2019 has come to an end, and 2020 is coming Standing at the turning point of new historical opportunities, when more and more "factors" such as policies, science and technology, capital and so on are more and more closely related to the pharmaceutical industry, we have to think about: how to empower "future medicine"? How to help the industry achieve high-quality development?